HSE’s mounting drug budget needs a shot of strong medicine

Some new treatments cost well over €100,000 per patient, but there are effective ways to rein in expenditure

5th January, 2020
HSE’s mounting drug budget needs a shot of strong medicine

There has been much criticism of the finite drug budget we have in the health service. Last year, even though the HSE invested heavily and funded 29 new medicines, new approvals stalled.

Affordability has become a real issue, even though drug expenditure in Ireland is likely to exceed €2.5 billion in 2019. That represents approximately 17 per cent of total healthcare expenditure in 2019.

Some new drug therapies cost well over €100,000 per patient per year and are frequently...

Subscribe from just €1 for the first month!

Exclusive offers:

All Digital Access + eReader

Trial

€1

Unlimited Access for 1 Month

Get basic

*New subscribers only

You can cancel any time.

Annual

€200

€149 For the 1st Year

Unlimited Access for 1 Year

You can cancel any time.

Quarterly

€55

€42

90 Day Pass

You can cancel any time.

2 Yearly

€315

€248

Unlimited Access for 2 Years

You can cancel any time.

Team Pass

Get a Business Account for you and your team

Share this post

Related Stories

Potential use of rapid antigen tests in workplaces and schools to be assessed

‘The next few weeks will give us hope if we can hang in there’

Health Danielle Barron 3 hours ago

Lifting of ban on visits to nursing homes now urged

Health Danielle Barron 3 hours ago

Deforestation, the wildlife trade and intensive farming: a recipe for lethal virus outbreaks

Health Daniel Murray 3 hours ago